Researchers have developed a scalable manufacturing platform for immunotherapy by enabling the long-term expansion of granulocyte-monocyte progenitors (GMPs). By identifying that myeloperoxidase (MPO) inhibition unlocks sustained proliferation, the authors created defined culture conditions to produce vast quantities of these myeloid precursors from both mice and humans. Unlike terminal macrophage...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动